Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (21 ops.)
Latest filing published 17 Sept 2026 for Travere Therapeutics, Inc., €302k. Read the official filing
Filing timeline
BuySaleChristopher R. Cline
Insider track record
Disclosed buys
0
Disclosed sells
21
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Christopher R. Cline: trading record in brief
Christopher R. Cline discloses dealings in Travere Therapeutics, Inc. to SEC (Form 4). In total, 31 filings cover trades dated from 1 September 2022 to 15 September 2026.
Every open-market trade on record is a sale: 21 sales worth €3.2M. Other entries cover 7 share grants and 3 option exercises. Since January 2026: no purchases and 10 sales on the market.
The latest filing, published on 17 September 2026, reports an open-market sale of €23k in Travere Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Christopher R. Cline
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations31 total
20,000 shares@ US$17.44Common StockSEC:0001943192-26-000006:0
27,473 shares@ US$61.9969Common StockSEC:0001943192-26-000006:1
20,735 shares@ US$62.6079Common StockSEC:0001943192-26-000006:2
1,900 shares@ US$63.6865Common StockSEC:0001943192-26-000006:3
400 shares@ US$65.31Common StockSEC:0001943192-26-000006:4
642 shares@ US$66.370.0007% mcap5.0% of flowCommon StockSEC:0001943192-26-000005:0
14,000 shares0Common StockSEC:0001943192-26-000003:0
65 shares@ US$28.850.0000% mcap0.4% of flowCommon StockSEC:0001943192-26-000003:1
9 shares@ US$41.070.0000% mcap0.1% of flowCommon StockSEC:0001943192-26-000003:2
7,239 shares@ US$41.92880.0055% mcap72.4% of flowCommon StockSEC:0001943192-26-000003:3
1,014 shares@ US$42.610.0008% mcap10.3% of flowCommon StockSEC:0001943192-26-000003:4
1,635 shares@ US$32.146.4% of flowCommon StockSEC:0001943192-26-000002:0
28,130 shares0Common StockSEC:0001943192-26-000001:0
20,000 shares@ US$16.2343.1% of flowCommon StockSEC:0001943192-25-000005:0
454 shares@ US$18.201.9% of flowCommon StockSEC:0001415889-25-023786:0
470 shares@ US$17.311.9% of flowCommon StockSEC:0001415889-25-023209:0
4,920 sharesCommon StockSEC:0001415889-25-012061:0
48 shares@ US$13.14460.9% of flowCommon StockSEC:0001415889-25-010643:0
21,500 shares0Common StockSEC:0001415889-25-003062:0
865 shares@ US$18.940926.5% of flowCommon StockSEC:0001415889-25-001999:0
6,750 shares0Common StockSEC:0001415889-24-023091:0
514 shares@ US$9.50937.4% of flowCommon StockSEC:0001415889-24-022992:0
54 shares@ US$6.740.6% of flowCommon StockSEC:0001415889-24-010754:0
25,000 shares0Common StockSEC:0001415889-24-002280:0
853 shares@ US$9.068412.0% of flowCommon StockSEC:0001415889-24-001798:0
25 of 31 declarations
